insights_auto
Why is ARGX down 2.00%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
$874.97
arrow_downward
-2.00%(-17.90) 1D
$875.06
arrow_upward
+0.01% (+0.090)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$893.27
High
$899.12
Low
$872.50
Mkt. cap
55.60B
Avg. vol.
438.32K
Volume
0.00
P/E ratio
30.24
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
Open
$893.27
High
$899.12
Low
$872.50
Mkt. cap
55.60B
Avg. vol.
438.32K
Volume
0.00
P/E ratio
30.24
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
FinSMEs
·
7 minutes ago
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq
Yahoo Finance
·
30 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Quantisnow
·
24 minutes ago
WISeQey Announces Preliminary Nine-Month 2026 Financial Results and Provides Corporate Update
Bloomberg.com
·
47 minutes ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR